Zogenix Inc
0.00 (0.0%)


Draw Mode:

Volume 0
Bid Price 29.46
Ask Price 26.68
News -
Company Name Stock Ticker Symbol Market Type
Zogenix Inc ZGNX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 26.68 20:00:00
Open Price Low Price High Price Close Price Prev Close
26.68 26.68
Trades Volume Avg Volume
0 0 -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 26.68 USD

Zogenix Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.50B 56.23M 50.22M $ 81.69M $ - -4.07 -6.60
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -1.25k 2.00%

more financials information »

Zogenix News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No ZGNX Message Board. Create One! See More Posts on ZGNX Message Board See More Message Board Posts

Historical ZGNX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.
1 Month0.
3 Months0.
6 Months0.
1 Year0.
3 Years0.
5 Years0.

Zogenix Description

Zogenix Inc is engaged in developing and commercializing therapeutic solutions for people living with serious and life-threatening rare CNS disorders and medical conditions. Its product candidate includes Fintepla, dose fenfluramine for the treatment of Dravet syndrome, and MT-1621 for a rare, life-threatening mitochondrial depletion disease, thymidine kinase 2 deficiency (TK2d). It operates as a single operating segment engaged in the research, development, and commercialization of pharmaceutical products.